On October 27, 2021, Harbert Discovery Fund, LP and Harbert Discovery Co-Investment Fund I, LP sent a letter to the independent members of the Board of Enzo Biochem, Inc., urging them (i) to make corporate governance changes that ensure newly appointed CEO, Hamid Erfanian, will have the authority to manage the business without interference from Elazar Rabbani; and (ii) to fulfill his or her fiduciary duties and represent the interests of all shareholders.